A critical role of protein damage response in mediating cancer drug resistance
Fangyuan Shao, Jie Li, Hao Xiao, Ling Li, Bo Li, Y H Chen, Xiangpeng Chu, Maoxin Ran, Dongyang Tang, Yuzhong Peng, Yujian Huang, Lijian Wang, Yanxia Shi, Nan Shao, Kai Miao, , Chu‐Xia Deng
This study identifies protein damage response (PDR) as a key mechanism in cancer drug resistance, showing that targeting PDR components can enhance drug efficacy in resistant cells.
bioRxiv · Jul 17, 2024 · PreprintCancer Biology